A pooled analysis of the incidence and mortality risk of atrial fibrillation in patients with COVID-19.

ABSTRACT:

Background

There exist serious cardiovascular complications subsequent to SARS-Cov2 infection (COVID-19); however, the association between COVID-19 and atrial fibrillation (AF) remains to be elucidated. We aimed to assess the prevalence of AF among COVID-19 patients and its associated risk of death.

Methods

The present systematic review was performed in accordance with the PRISMA guidelines. The protocol was registered with CRD42022306523. A comprehensive literature search was performed across PubMed, Embase, and Cochrane databases to identify studies reporting on the prevalence of pre-existing or new-onset fibrillation (AF), and/or the associated clinical outcomes in patients with COVID-19 from January 2020 to December 2023. The random-effect model was used to estimate the

SUBMITTER: Shen NN 

PROVIDER: S-EPMC11490229 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature